Retatrutide 5mg + Cagrilintide 5mg Blend

This blend combines the triple receptor agonist Retatrutide with Cagrilintide (5mg each) for maximized metabolic pathway activation. Research indicates this combination may provide synergistic effects on appetite suppression, weight loss, and metabolic function. This advanced blend is studied for the most potent metabolic intervention available.